BANSAL AJAY (PFO;CFO/Urovant Sciences, Inc.) reported 2 transactions at UROVANT SCIENCES LTD.
Review the transaction codes below to understand the nature of each event.
Filed: 3/31/2021ACC: 0000899243-21-014104
Officer· PFO;CFO/Urovant Sciences, Inc.
Since Oct 2019
-280.10K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
280.10K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
−24.88K
Price / share
—
Trade value
—
% of position
New position
3/29/2021
24.88K→0.00
Common Shares
Direct
Shares
−115.22K
Price / share
—
Trade value
—
% of position
New position
3/29/2021
115.22K→0.00
Total
Net shares
−140.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/29/2021 | D · Disposition | −24.88K | — | — | New position | 24.88K | 0.00 |
| Common Shares Direct | 3/29/2021 | D · Disposition | −115.22K | — | — | New position | 115.22K | 0.00 |
| Total | −140.10K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
140K shares
Shares
−140K
Strike price
9.66
Held after
0.00
Exercisable
—
3/29/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares140K shares | 3/29/2021 | D · Disposition | −140K | 9.66 | — | 0.00 |